PCRによる呼吸器感染症診断市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00023326
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 284
Buy Now

呼吸器感染症診断用の PCR 市場は、2021 年の 4 億 1 億 4,602 万米ドルから、2028 年までに 8 億 7,932 万米ドルと評価されました。 2021 年から 2028 年までに 10.4% の CAGR で成長すると推定されています。



ポリメラーゼ連鎖反応 (PCR) は、気道感染症の原因を迅速に特定して特定するのに役立つ正確なポイントオブケア診断に使用されます。さらに、PCR は入院患者および外来患者の設定で広く好まれており、近年の市場の成長促進に貢献しています。



呼吸器感染症診断市場における PCR の成長は、負担の増加などの要因に起因しています。慢性呼吸器疾患 (CRD) の増加に伴い、PCR 検査の開発が進み、医療機器の性能が大幅に向上しています。しかし、さまざまな呼吸器感染症の診断のための PCR 検査の使用と、それらを導き出すための PCR 技術の開発が行われています。代替アッセイの利用可能性が市場の成長を妨げています。



呼吸器感染症診断市場における PCR の有利な地域



市場洞察



PCR の使用によって採用された市場統合戦略さまざまな呼吸器感染症の診断のための検査



PCR 検査は、SARS-CoV-2 を含む呼吸器感染症を検出するためのゴールドスタンダードです。また、PCR の発展の進展は、新型コロナウイルス感染症検査に限定されません。継続的な技術開発により、研究者は低コストで高度な PCR 技術を開発し、その複雑さを制限できるようになりました。マイクロ流体工学や次世代シークエンシングなどの技術の発展により、PCR検査は分子診断の能力を強化し、将来的にその役割を強化すると期待されています。さらに、PCR 検査は、呼吸器疾患の流行を引き起こすインフルエンザ ウイルス感染を特定するために、老人ホーム、慢性期ケア施設、病院などの施設で広く使用されています。



さらに、急性および慢性呼吸器感染症は、主要な感染症の 1 つです。世界中の先進国と発展途上国における罹患率の原因。急性呼吸器疾患は、全世界の急性疾患全体のほぼ 75% を占めると推定されています。そのため、さまざまな企業が、呼吸器疾患を引き起こす病原体の存在を検出できるさまざまな PCR キットを提供しています。たとえば、bioMérieux SA や altona Diagnostics GmbH などの企業は、上気道または下気道の急性呼吸器感染症を検出できる幅広い PCR キットを提供しています。急性および慢性の呼吸器疾患の発生率の増加とは別に、環境および気候条件、大気汚染、新種の細菌、ウイルス、病原体の発見などの他の要因が、呼吸器感染症診断のための PCR 検査の重要な成長機会となる可能性があります。



タイプベースの洞察



呼吸器感染症診断市場の PCR は、タイプ別に、リアルタイム PCR (qPCR)、マルチプレックス PCR、従来型 PCR、デジタル PCR に分類されます。 PCR、逆転写酵素 (RT-PCR) など。リアルタイム PCR (qPCR) セグメントは 2021 年に市場で最大のシェアを占め、予測期間中に市場で最高の CAGR を記録すると予想されています。



呼吸器感染症診断市場向け PCR (タイプ別) - 2021 年と 2028 年



製品タイプベースの洞察



製品タイプに基づいて、呼吸器感染症診断用 PCR 市場は試薬とキット、機器などに分類されます。試薬およびキットセグメントは2021年に市場で最大のシェアを占め、予測期間中に市場で最高のCAGRを記録すると予想されています。



感染の種類に基づく洞察



感染の種類に基づいて、呼吸器感染症診断用の PCR 市場は細菌感染、ウイルス感染、真菌およびその他の病原体に分類されます。 2021年には、ウイルス感染症セグメントが市場で最大のシェアを占め、予測期間中に市場で最高のCAGRを記録すると推定されています。



エンドユーザーベースの洞察



エンドユーザーに基づいて、呼吸器感染症診断用 PCR 市場は病院、診療所、臨床検査室、学術研究機関、バイオテクノロジー、製薬に分類されます。企業、その他。 2020 年、臨床検査部門が市場で最大のシェアを占め、予測期間中に市場で最高の CAGR を記録すると推定されています。



戦略的洞察



製品の発売と承認これらは、企業が世界的な拠点と製品ポートフォリオを拡大するために一般的に採用する戦略です。さらに、乳房再建市場のプレーヤーは、顧客層を拡大するためのコラボレーション戦略に焦点を当てており、これにより、世界的にブランド名を維持できるようになります。



タイプ別





  • リアルタイム PCR (qPCR)

  • マルチプレックス PCR

  • 従来の PCR

  • デジタル PCR

  • 逆転写酵素 (RT-PCR)< /li>
  • その他


製品タイプ別





  • 試薬およびキット

  • 機器

  • その他


感染症の種類別





  • 細菌感染症

    • ボルデテラ菌

    • 肺炎球菌

    • ブドウ球菌黄色ブドウ球菌

    • インフルエンザ菌

    • モラクセラ・カタルハリス

    • 肺炎マイコプラズマ

    • 肺炎クラミドフィラ

    • レジオネラ菌

    • < li>その他


  • ウイルス感染症

    • ライノウイルス

    • インフルエンザウイルス

    • 重症急性呼吸器症候群(SARS) CoV-2 ウイルス

    • 呼吸器合胞体ウイルス (RSV)

    • アデノウイルス

    • エンテロウイルス

    • パラインフルエンザ

    • ヒトメタニューモウイルス(hMPV)

    • その他



  • 真菌およびその他の病原体


エンドユーザーによる



  • 病院

  • 診療所

  • 臨床研究所

  • 学術機関および研究機関

  • バイオテクノロジー企業および製薬会社

  • < li>その他

地理別





  • 北米

    • 米国

    • カナダ

    • メキシコ



  • ヨーロッパ

    • フランス

    • ドイツ

    • イギリス

    • スペイン
    • オランダ

    • ノルウェー

    • イタリア

    • その他のヨーロッパ



  • アジア太平洋 ( APAC)

    • 中国

    • インド

    • 日本

    • オーストラリア

    • 韓国

    • 残りアジア太平洋地域



  • 中東およびアフリカ (MEA)

    • サウジアラビア

    • アラブ首長国連邦

    • 南アフリカ

    • 中東およびアフリカの残りの地域



  • 中南米 (SCAM)

    • ブラジル

    • アルゼンチン

    • その他の中南米




会社概要





  • アボット

  • F. Hoffmann-La Roche AG
  • Hologic, Inc.

  • Seegene Inc.

  • AusDiagnostics

  • BD

  • バイオ-Rad Laboratories Inc

  • BioMérieux

  • Qiagen

  • Thermo Fisher Scientific Inc


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is PCR test mean?

The polymerase chain reaction (PCR) is a simple and low-cost method for amplifying small portions of DNA. Because significant amounts of a sample of DNA are necessary for molecular and genetic analyze, studies of isolated fragments of DNA are almost impossible without PCR amplification.

What are the driving factors for the PCR for respiratory infection diagnostics market across the globe?

The growth of the market is attributed to some key driving factors such as as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth. In January 2020, Roche received CE Mark approval for an adenovirus test for transplant patients. It is intended to be used in conjunction with other infectious diseases tests available on their cobas systems (6800 and 8800). The majority of companies are now offering real-time polymerase chain reaction (PCR) tests for corona virus, which is contributing to the growth of the target market.Such strategic steps are also projected to drive the market growth.

What is the regional analysis in terms of PCR for respiratory infection diagnostics?

The growth of the region is attributed to factors such as rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical devices. Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in Asia Pacific. In addition, the Europe is expected account for the fastest growth in the PCR for respiratory infection diagnostics market. A high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical devices growth of Europe PCR for respiratory infection diagnostics market during the forecast period.

The List of Companies - PCR for Respiratory Infection Diagnostic Market

  1. Abbott
  2. F. Hoffmann-La Roche AG
  3. Hologic, Inc.
  4. Seegene Inc.
  5. AusDiagnostics
  6. BD
  7. Bio-Rad Laboratories Inc
  8. BioMérieux
  9. Qiagen
  10. Thermo Fisher Scientific Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports